Table 2.
Clinical information of the patients.
| Variables | Total (n = 180) |
IPD (n = 90) |
OPD (n = 90) |
p Value | |
|---|---|---|---|---|---|
| No. (%) | No. (%) | No. (%) | |||
| Co-morbidities | DM | 53 (29.4) | 29 (32.2) | 24 (26.7) | |
| HT | 65 (36.1) | 34 (37.8) | 31 (34.4) | p = 0.33 | |
| Heart disease | 29 (16.1) | 10 (11.1) | 19 (21.1) | ||
| Others | 33 (18.3) | 17 (18.9) | 16 (17.8) | ||
| Stage of CKD | 1 | 36 (20) | 3 (3.3) | 33 (36.7) | |
| 2 | 49 (27.2) | 17 (18.9) | 32 (35.6) | ||
| 3 | 51 (28.3) | 34 (37.8) | 17 (18.9) | p = 0.001 | |
| 4 | 33 (18.3) | 27 (30) | 6 (6.7) | ||
| 5 | 11 (6.1) | 9 (10) | 2 (3) | ||
| Duration of CKD | 1–3 years | 38 (21.1) | 8 (8.9) | 38 (42.3) | |
| 4–6 years | 53 (29.1) | 29 (32.2) | 24 (26.7) | p = 0.001 | |
| 7–9 years | 54 (30) | 38 (42.2) | 16 (17.8) | ||
| 10 and above years | 27 (15) | 15 (16.7) | 12 (13.3) | ||
| Treatment of CKD | HD | 54 (30) | 38 (42.2) | 16 (17.8) | |
| Immunosuppressants | 74 (41.1) | 32 (35.6) | 42 (46.7) | p = 0.001 | |
| Others | 52 (28.9) | 20 (22.2) | 32 (35.6) | ||
No—number; %—percentage; statistically significant at p < 0.05.